Natural products target the NRF2-ferroptosis axis in hepatocellular carcinoma: tumor sensitization versus hepatoprotection

Zugen Cheng, Ping Rong

Open source

DOI
10.3389/fphar.2026.1968548
Published
2026-10-22
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1968548,
  title = {Natural products target the NRF2-ferroptosis axis in hepatocellular carcinoma: tumor sensitization versus hepatoprotection},
  author = {Zugen Cheng and Ping Rong},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1968548},
  url = {https://doi.org/10.3389/fphar.2026.1968548}
}

RIS

TY  - JOUR
TI  - Natural products target the NRF2-ferroptosis axis in hepatocellular carcinoma: tumor sensitization versus hepatoprotection
AU  - Zugen Cheng
AU  - Ping Rong
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1968548
UR  - https://doi.org/10.3389/fphar.2026.1968548
ER  - 

APA

Cheng, Z., & Rong, P. (2026). Natural products target the NRF2-ferroptosis axis in hepatocellular carcinoma: tumor sensitization versus hepatoprotection. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1968548

Source records